Home/Filings/4/0001437749-26-000924
4//SEC Filing

AUERBACH ALAN H 4

Accession 0001437749-26-000924

CIK 0001401667other

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 8:27 PM ET

Size

6.0 KB

Accession

0001437749-26-000924

Insider Transaction Report

Form 4
Period: 2026-01-06
AUERBACH ALAN H
DirectorPresident and CEO10% Owner
Transactions
  • Sale

    Common Stock

    2026-01-06$5.84/sh16,938$98,9867,163,963 total
  • Sale

    Common Stock

    2026-01-07$5.88/sh18,012$105,8937,145,951 total
Footnotes (1)
  • [F1]Adoption date of referenced 10b5-1(c) plan is: 12-17-2020

Issuer

PUMA BIOTECHNOLOGY, INC.

CIK 0001401667

Entity typeother

Related Parties

1
  • filerCIK 0001358285

Filing Metadata

Form type
4
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 8:27 PM ET
Size
6.0 KB